This manuscript provides valuable high-resolution structural insights into the interaction between vaccine-elicited antibodies and SARS‑CoV‑2 evolution. The evidence is solid; however, the conclusions ...
Bivalent EABR mRNA boosters broaden neutralizing responses to Omicron subvariants by promoting diverse receptor-binding domain epitope targeting, although antibody responses remain partially shaped by ...
100% of patients achieved rapid, sustained improvements across MG-ADL and QMG at 24 weeks, further increasing confidence in Phase 3 trial Totality of efficacy and safety data reinforces miv-cel’s ...
Although some of the criticisms of Robert F. Kennedy Jr.'s MAHA movement are spot on, why did KevinMD platform a practitioner ...
Detailed price information for Kyverna Therapeutics Inc (KYTX-Q) from The Globe and Mail including charting and trades.
Phase 2 trial data have shown that the CD38-targeting antibody mezagitamab can rapidly restore platelet counts in immune thrombocytopenia, with strong response rates at higher doses and a safety ...
Researchers from Queen Mary University of London have uncovered a previously unknown mechanism by which HIV-1 can infect ...
Infection-fighting T cells from people who have eaten recently can proliferate more quickly in response to threats.
Activated immune cells secrete tiny capsules bearing DNA that can enter other immune and tumor cells to stimulate the body's ...
T cells, which target infection and disease, can become more effective after a meal. The finding might help improve ...
Chimeric antigen receptor-T (CAR-T) cell therapy represents a major breakthrough in cancer immunotherapy, providing remarkable clinical benefits for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results